Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
264.00    -2.00 (-0.75%)
Bid:
262.00
Ask:
264.00
Spread: 2.00 (0.763%)
Market Cap: £236.43m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Acquisition

19 Jan 2016 07:00

RNS Number : 2460M
Wilmington PLC
19 January 2016
 

 

19 January 2016

Wilmington plc

 

Acquisition of JMH Publishing Limited trading as "Wellards"

 

· Acquisition adds online education capability for the Insight knowledge area 

 

· Wellards extensive NHS knowledge base strengthens Wilmington's Healthcare offering

 

· High quality revenue streams - 70% from subscription products with over 90% renewal rates

 

Wilmington plc ("Wilmington" or "the Group"), the knowledge leader in Risk & Compliance, Finance, Legal, and Insight, announces the acquisition of JMH Publishing Ltd ("Wellards" or "the business"), a leading UK provider of specialist and accredited online education for the healthcare industry and owner of the respected trading brand "Wellards".

 

As part of Wilmington, Wellards will become the principal education and training platform for the Insight division and will benefit from Wilmington's enhanced healthcare market access, both in the UK and in mainland Europe.

 

Terms of the deal

 

Wilmington is acquiring Wellards for an initial consideration of £4.2m payable in cash. Wellards is being acquired with £1.3m of cash in its balance sheet. A final payment of up to £0.9m in March 2016 will be made once the final net current asset position has been agreed.

 

The consideration will be financed out of the Group's existing £65.0m multicurrency debt facility and is expected to be earnings enhancing in the first full year of ownership.

 

Background to Wellards

 

Wellards, established in 1990 is based in Kent, England and is managed by its founder John Heath, CEO who will remain with the business for a transitional period of one year. Wellards core online modules deliver the industry standard for effective and comprehensive NHS training and are an indispensable resource to enable understanding of the NHS and how it functions.

 

Wellards runs over 70 online courses and has more than 25,000 registered users. Subjects covered include critical areas for pharma industry representatives such as market access and financial flows, clinical modules of key therapy areas such as cancer, diabetes and cardiovascular health, ABPI code and compliance. Over 70% of its revenue is generated by its online training portal, Wellards Academy, which services the needs of UK pharmaceutical and Medtech commercial staff.

 

In the twelve month period ended 31 October 20151, revenue per the unaudited management accounts was £2.0m, an increase of 12 percent on the same period in 2014 and the adjusted profit before interest, amortisation and taxation was £0.6m1. Gross assets were 2.0m1. Wellards will provide Wilmington with an additional attractive recurring revenue stream as over 70% of its revenue is subscription based with over 90% renewal rates.

 

Acquisition rationale

 

The acquisition of Wellards is consistent with Wilmington's strategy of acquiring complementary businesses with high repeat revenues and strong, cash generative income streams in the Group's key markets. The addition of Wellards provides Wilmington with education capability for its Insight division completing the strategic objective of having information, networking and education offerings across all of Wilmington's four knowledge areas.

 

1 unaudited.

 

Commenting on the acquisition, Pedro Ros, Chief Executive Officer of Wilmington, said:

 

"I am delighted to welcome Wellards to Wilmington; its addition completes one of our strategic objectives of having information, education and networking capabilities for each of our knowledge areas. I am particularly excited by the scalability of the online products both in the broader healthcare industry and internationally where we can utilise our existing market access in particular to the French and German healthcare markets."

 

John Heath, founder and CEO of Wellards commented: 

 

"I'm delighted that Wellards is now part of Wilmington. For many years we have worked closely with Binleys; a business within Wilmington's Insight division, providing customers with the knowledge and insight needed to interpret the practical value of the Binleys resource and this acquisition is a very natural extension of our partnership.

 

I'm looking forward to developing new services which will enhance the product portfolio of both companies"

 

For further information, please contact:

Wilmington plc

Pedro Ros, Chief Executive Officer

Tony Foye, Chief Financial Officer

020 7422 6800

FTI Consulting

Charles Palmer

Emma Appleton

020 3727 1000

 

Notes to Editors

 

Wilmington plc is the recognised knowledge leader and partner of choice for information, education and networking in Risk & Compliance, Finance and Legal as well as the Insight leader in a number of chosen industries. Capitalised at approximately £225 million, Wilmington floated on the London Stock Exchange in 1995.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQFVLLFQFFBBBF
Date   Source Headline
1st Mar 20171:58 pmRNSVoting Rights and Capital
24th Feb 20172:29 pmRNSDirector/PDMR Shareholding
23rd Feb 20179:36 amRNSInterim Results - Update
23rd Feb 20177:00 amRNSInterim Results
1st Feb 20171:10 pmRNSVoting Rights and Capital
1st Feb 20177:00 amRNSCompletion of Health Service Journal
19th Jan 20177:04 amRNSAcquisition of Health Service Journal
18th Jan 20175:08 pmRNSHolding(s) in Company
17th Jan 20174:43 pmRNSHolding(s) in Company
12th Jan 20179:00 amRNSNotice of Interim Results
3rd Jan 201712:20 pmRNSTotal Voting Rights and Capital
16th Dec 20163:22 pmRNSHolding(s) in Company
1st Dec 20167:00 amRNSVoting Rights and Capital
3rd Nov 20164:03 pmRNSResult of AGM
3rd Nov 20167:00 amRNSAGM and Q1 Trading update
1st Nov 20167:00 amRNSVoting Rights and Capital
17th Oct 201612:53 pmRNSHolding(s) in Company
3rd Oct 201610:05 amRNSVoting Rights and Capital
21st Sep 20162:48 pmRNSDirector/PDMR Shareholdings
20th Sep 201611:54 amRNSShare Awards
16th Sep 20164:31 pmRNSReplacement: Share Awards and Options
16th Sep 20169:10 amRNSShare Awards and Options
14th Sep 20167:00 amRNSFinal Results
2nd Sep 20161:48 pmRNSHolding(s) in Company
1st Sep 20169:39 amRNSVoting Rights and Capital
11th Aug 201610:31 amRNSNotice of Final Results
1st Aug 20169:44 amRNSVoting Rights and Capital
21st Jul 20169:41 amRNSHolding(s) in Company
20th Jul 20167:00 amRNSAcquisition of SWAT
1st Jul 20167:00 amRNSVoting Rights and Capital
10th Jun 20165:04 pmRNSHolding(s) in Company
1st Jun 201611:55 amRNSVoting Rights and Capital
23rd May 201611:57 amRNSHolding(s) in Company
12th May 20167:00 amRNSInterim Management Statement
4th May 20164:05 pmRNSHolding(s) in Company
4th May 20163:54 pmRNSHolding(s) in Company
3rd May 201610:03 amRNSTotal Voting Rights
29th Apr 20169:33 amRNSChange of Company Secretary
1st Apr 20169:33 amRNSTotal Voting Rights
29th Mar 20167:00 amRNSAcquisition
18th Mar 20163:10 pmRNSHolding(s) in Company
11th Mar 20162:03 pmRNSDirector/PDMR Shareholding
1st Mar 20164:37 pmRNSTotal Voting Rights
24th Feb 20167:00 amRNSInterim Results
1st Feb 20169:37 amRNSTotal Voting Rights
19th Jan 20167:00 amRNSAcquisition
15th Jan 20169:52 amRNSHolding(s) in Company
12th Jan 201610:54 amRNSNotification of Interim Results
4th Jan 201611:12 amRNSTotal Voting Rights
17th Dec 20157:00 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.